Evidence map›Paper›PMID 35981863›Full record

ArticleSexually transmitted infections2023

How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID).

Emily Dema, Pam Sonnenberg, Jo Gibbs, Anne Conolly, Malachi Willis, Julie Riddell, Raquel Bosó Pérez, Andrew J Copas, Clare Tanton, Chris Bonell and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Sexually transmitted infections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Emily DemaInstitute for Global Health, University College London, London, UK emily.dema.19@ucl.ac.uk.ORCID 0000-0002-7254-2023
Pam SonnenbergInstitute for Global Health, University College London, London, UK.
Jo GibbsInstitute for Global Health, University College London, London, UK.ORCID 0000-0001-5696-0260
Anne ConollyInstitute for Global Health, University College London, London, UK.
Malachi WillisSocial and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK.
Julie RiddellSocial and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK.ORCID 0000-0002-8084-4566
Raquel Bosó PérezSocial and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK.
Andrew J CopasInstitute for Global Health, University College London, London, UK.ORCID 0000-0001-8968-5963
Clare TantonFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Chris BonellFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Clarissa OeserInstitute for Global Health, University College London, London, UK.
Soazig CliftonInstitute for Global Health, University College London, London, UK.
Magnus UnemoDepartment of Laboratory Medicine, Örebro University Hospital, Orebro, Sweden.
Catherine H MercerInstitute for Global Health, University College London, London, UK.ORCID 0000-0002-4220-5034
Kirstin R MitchellSocial and Public Health Sciences Unit, University of Glasgow MRC/CSO, Glasgow, UK.
Nigel FieldInstitute for Global Health, University College London, London, UK.ORCID 0000-0002-2825-6652
University College London · GBMRC/CSO Social and Public Health Sciences Unit · GBLondon School of Hygiene & Tropical Medicine · GBNatCen Social Research · GBÖrebro University Hospital · SEUK Dementia Research Institute · GB

Funding

Chief Scientist Office SPHSU18Department of HealthMedical Research Council MC_UU_00022/3Wellcome TrustWellcome Trust 212931/Z/18/Z
6 · The paper itself

Abstract

objectivesTo investigate how differential access to key interventions to reduce STIs, HIV and their sequelae changed during the COVID-19 pandemic.

methodsBritish participants (18-59 years) completed a cross-sectional web survey 1 year (March-April 2021) after the initial lockdown in Britain. Quota-based sampling and weighting resulted in a quasi-representative population sample. We compared Natsal-COVID data with Natsal-3, a household-based probability sample cross-sectional survey (16-74 years) conducted in 2010-2012. Reported unmet need for condoms because of the pandemic and uptake of chlamydia testing/HIV testing/cervical cancer screening were analysed among sexually experienced participants (18-44 years) (n=3869, Natsal-COVID; n=8551, Natsal-3). ORs adjusted for age and other potential confounders describe associations with demographic and behavioural factors.

resultsIn 2021, 6.9% of women and 16.2% of men reported unmet need for condoms because of the pandemic. This was more likely among participants: aged 18-24 years, of black or black British ethnicity, and reporting same-sex sex (past 5 years) or one or more new relationships (past year). Chlamydia and HIV testing were more commonly reported by younger participants, those reporting condomless sex with new sexual partners and men reporting same-sex partners; a very similar distribution to 10 years previously (Natsal-3). However, there were differences during the pandemic, including stronger associations with chlamydia testing for men reporting same-sex partners; with HIV testing for women reporting new sexual partners and with cervical screening among smokers.

conclusionsOur study suggests differential access to key primary and secondary STI/HIV prevention interventions continued during the first year of the COVID-19 pandemic. However, there was not strong evidence that differential access has changed during the pandemic when compared with 2010-2012. While the pandemic might not have exacerbated inequalities in access to primary and secondary prevention, it is clear that large inequalities persisted, typically among those at greatest STI/HIV risk.

Indexed as

Acquired Immunodeficiency SyndromeChlamydiaCOVID-19HIV InfectionsSexually Transmitted DiseasesUterine Cervical NeoplasmsCommunicable Disease ControlCondomsCross-Sectional StudiesEarly Detection of CancerFemaleHIV TestingHumansMalePandemicsSexual BehaviorCONDOMSCOVID-19Diagnostic Screening ProgramsHIVSEXUAL HEALTH

Identifiers

PMID35981863
PMCPMC10313967
OpenAlexW4292248701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.